Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,694 | -38,204 | -17,598 | -70,480 | -73,708 |
| Depreciation Amortization | -414 | -276 | -118 | -172 | -110 |
| Accounts receivable | -7,475 | -2,856 | -1,537 | -4,077 | -3,273 |
| Accounts payable and accrued liabilities | -3,730 | -2,614 | -5,212 | 3,755 | 5 |
| Other Working Capital | 5,362 | 12,236 | 12,503 | 4,122 | -2,299 |
| Other Operating Activity | 24,090 | 14,494 | 11,393 | 8,026 | 8,915 |
| Operating Cash Flow | $-31,861 | $-17,220 | $-569 | $-58,826 | $-70,470 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,195 | -15,253 | -696 | 26,070 | 23,908 |
| PPE Investments | -844 | -492 | -377 | -1,106 | -1,037 |
| Investing Cash Flow | $-16,039 | $-15,745 | $-1,073 | $24,964 | $22,871 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 882 | 872 | 16 | 71,894 | 70,795 |
| Other Financing Activity | 9,789 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $10,671 | $872 | $16 | $71,894 | $70,795 |
| Beginning Cash Position | 76,322 | 76,322 | 76,322 | 38,290 | 38,290 |
| End Cash Position | 39,093 | 44,229 | 74,696 | 76,322 | 61,486 |
| Net Cash Flow | $-37,229 | $-32,093 | $-1,626 | $38,032 | $23,196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,861 | -17,220 | -569 | -58,826 | -70,470 |
| Capital Expenditure | -844 | -492 | -377 | -1,106 | -1,037 |
| Free Cash Flow | -32,705 | -17,712 | -946 | -59,932 | -71,507 |